Drugs / ORILOTIMOD
ORILOTIMOD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01483924 | Nov 2011 → Aug 2013 | psoriasis | ApoPharma | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ORILOTIMOD | ChEMBL registry synonym — accepted as the source's own label CHEMBL3137306 ↗ |
| Known as | APO-805 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3137306 ↗ |
| Known as | Apo805K1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01483924 ↗ |
| Known as | ORILOTIMOD POTASSIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL3137306 ↗ |
| Known as | Thymodepressin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3137306 ↗ |
| Known as | Timodepressin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3137306 ↗ |
| Modality | Small molecule | — CHEMBL3137306 ↗ |